Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease.

Anderson A, Click B, Ramos-Rivers C, Koutroubakis IE, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A 3rd, Regueiro M, Binion DG.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1380-1388. doi: 10.1093/ibd/izy040.

PMID:
29860492
2.

Ileocecal Anastomosis Type Significantly Influences Long-Term Functional Status, Quality of Life, and Healthcare Utilization in Postoperative Crohn's Disease Patients Independent of Inflammation Recurrence.

Gajendran M, Bauer AJ, Buchholz BM, Watson AR, Koutroubakis IE, Hashash JG, Ramos-Rivers C, Shah N, Lee KK, Cruz RJ, Regueiro M, Zuckerbraun B, Schwartz M, Swoger J, Barrie A, Harrison J, Hartman DJ, Salgado J, Rivers WM, Click B, Anderson AM, Umapathy C, Babichenko D, Dunn MA, Binion DG.

Am J Gastroenterol. 2018 Apr;113(4):576-583. doi: 10.1038/ajg.2018.13. Epub 2018 Mar 6.

PMID:
29610509
3.

Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial.

Dulai PS, Buckey JC Jr, Raffals LE, Swoger JM, Claus PL, O'Toole K, Ptak JA, Gleeson MW, Widjaja CE, Chang JT, Adler JM, Patel N, Skinner LA, Haren SP, Goldby-Reffner K, Thompson KD, Siegel CA.

Am J Gastroenterol. 2018 Feb 16. doi: 10.1038/s41395-018-0005-z. [Epub ahead of print]

PMID:
29453383
4.

Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.

Lukach AJ, Saul MI, Ferris LK, Swoger JM.

Dig Dis Sci. 2018 Mar;63(3):755-760. doi: 10.1007/s10620-018-4919-5. Epub 2018 Jan 22.

PMID:
29357084
5.

Epithelioid Granulomas Associate With Increased Severity and Progression of Crohn's Disease, Based on 6-Year Follow-Up.

Johnson CM, Hartman DJ, Ramos-Rivers C, Rao BB, Bhattacharya A, Regueiro M, Schwartz M, Swoger J, Al Hashash J, Barrie A, Pfanner TP, Dunn M, Koutroubakis IE, Binion DG.

Clin Gastroenterol Hepatol. 2018 Jun;16(6):900-907.e1. doi: 10.1016/j.cgh.2017.12.034. Epub 2017 Dec 24.

PMID:
29277619
6.

Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype.

Click B, Anderson AM, Koutroubakis IE, Rivers CR, Babichenko D, Machicado JD, Hartman DJ, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A III, Wenzel SE, Regueiro M, Binion DG.

Am J Gastroenterol. 2017 Dec;112(12):1849-1858. doi: 10.1038/ajg.2017.402. Epub 2017 Nov 7.

PMID:
29112200
7.

Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis.

Anderson A, Click B, Ramos-Rivers C, Cheng D, Babichenko D, Koutroubakis IE, Hashash JG, Schwartz M, Swoger J, Barrie AM 3rd, Dunn MA, Regueiro M, Binion DG.

Inflamm Bowel Dis. 2017 Dec;23(12):2180-2188. doi: 10.1097/MIB.0000000000001251.

PMID:
29084081
8.

Antigen Availability and DOCK2-Driven Motility Govern CD4+ T Cell Interactions with Dendritic Cells In Vivo.

Ackerknecht M, Gollmer K, Germann P, Ficht X, Abe J, Fukui Y, Swoger J, Ripoll J, Sharpe J, Stein JV.

J Immunol. 2017 Jul 15;199(2):520-530. doi: 10.4049/jimmunol.1601148. Epub 2017 Jun 12.

PMID:
28607113
9.

Telephone Encounters Predict Future High Financial Expenditures in Inflammatory Bowel Disease Patients: A 3-Year Prospective Observational Study.

Click B, Anderson AM, Ramos Rivers C, Koutroubakis IE, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A 3rd, Szigethy E, Regueiro M, Schoen RE, Binion DG.

J Clin Gastroenterol. 2018 Apr;52(4):319-325. doi: 10.1097/MCG.0000000000000801.

PMID:
28452828
10.

Validation of a tool predicting important findings on computed tomography among Crohn's disease patients.

Govani SM, Waljee AK, Kocher KE, Swoger JM, Saul M, Higgins PD.

United European Gastroenterol J. 2017 Mar;5(2):270-275. doi: 10.1177/2050640616658218. Epub 2016 Jul 8. Review.

11.

Defined chromosome structure in the genome-reduced bacterium Mycoplasma pneumoniae.

Trussart M, Yus E, Martinez S, Baù D, Tahara YO, Pengo T, Widjaja M, Kretschmer S, Swoger J, Djordjevic S, Turnbull L, Whitchurch C, Miyata M, Marti-Renom MA, Lluch-Senar M, Serrano L.

Nat Commun. 2017 Mar 8;8:14665. doi: 10.1038/ncomms14665.

12.

The Cost of Crohn's Disease: Varied Health Care Expenditure Patterns Across Distinct Disease Trajectories.

Rao BB, Click BH, Koutroubakis IE, Ramos Rivers C, Regueiro M, Swoger J, Schwartz M, Hashash J, Barrie A, Dunn MA, Binion DG.

Inflamm Bowel Dis. 2017 Jan;23(1):107-115. doi: 10.1097/MIB.0000000000000977.

13.

pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion.

Ozga AJ, Moalli F, Abe J, Swoger J, Sharpe J, Zehn D, Kreutzfeldt M, Merkler D, Ripoll J, Stein JV.

J Exp Med. 2016 Nov 14;213(12):2811-2829. Epub 2016 Oct 31.

14.

Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active Inflammation.

Bhattacharya A, Rao BB, Koutroubakis IE, Click B, Vargas EJ, Regueiro M, Schwartz M, Swoger JM, Babichenko D, Hartmann D, Rivers CR, Barrie A 3rd, Hashash JG, Dunn MA, Binion DG.

Inflamm Bowel Dis. 2016 Nov;22(11):2665-2671.

PMID:
27753691
15.

Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping.

Anderson AJ, Click B, Ramos-Rivers C, Babichenko D, Koutroubakis IE, Hartman DJ, Hashash JG, Schwartz M, Swoger J, Barrie AM 3rd, Dunn MA, Regueiro M, Binion DG.

Dig Dis Sci. 2016 Nov;61(11):3236-3245. Epub 2016 Sep 12.

16.

Compensatory Cell Movements Confer Robustness to Mechanical Deformation during Embryonic Development.

Jelier R, Kruger A, Swoger J, Zimmermann T, Lehner B.

Cell Syst. 2016 Aug;3(2):160-171. doi: 10.1016/j.cels.2016.07.005. Epub 2016 Aug 11.

17.

Group-Based Trajectory Modeling of Healthcare Financial Charges in Inflammatory Bowel Disease: A Comprehensive Phenotype.

Jiang J, Click B, Anderson AM, Koutroubakis IE, Rivers CR, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A, Regueiro M, Chang CC, Binion DG.

Clin Transl Gastroenterol. 2016 Jul 14;7(7):e181. doi: 10.1038/ctg.2016.39.

18.

Correlation of anemia status with worsening bowel damage as measured by Lémann Index in patients with Crohn's disease.

Bhagya Rao B, Koutroubakis IE, Rivers CR, Regueiro M, Swoger J, Schwartz M, Baidoo L, Hashash J, Barrie A, Dunn MA, Binion DG.

Dig Liver Dis. 2016 Jun;48(6):626-31. doi: 10.1016/j.dld.2016.02.020. Epub 2016 Mar 2.

PMID:
27005859
19.

Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.

Kabbani TA, Koutroubakis IE, Schoen RE, Ramos-Rivers C, Shah N, Swoger J, Regueiro M, Barrie A, Schwartz M, Hashash JG, Baidoo L, Dunn MA, Binion DG.

Am J Gastroenterol. 2016 May;111(5):712-9. doi: 10.1038/ajg.2016.53. Epub 2016 Mar 8.

PMID:
26952579
20.

Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease.

Click B, Ramos Rivers C, Koutroubakis IE, Babichenko D, Anderson AM, Hashash JG, Dunn MA, Schwartz M, Swoger J, Baidoo L, Barrie A 3rd, Regueiro M, Binion DG.

Inflamm Bowel Dis. 2016 Jun;22(6):1442-9. doi: 10.1097/MIB.0000000000000763.

21.

Light sheet fluorescence microscopy for in situ cell interaction analysis in mouse lymph nodes.

Abe J, Ozga AJ, Swoger J, Sharpe J, Ripoll J, Stein JV.

J Immunol Methods. 2016 Apr;431:1-10. doi: 10.1016/j.jim.2016.01.015. Epub 2016 Feb 2.

PMID:
26844990
22.

Delineation of Crohn's Disease Trajectories Using Change in Lémann Index: A Natural History Study.

Bhagya Rao B, Koutroubakis IE, Ramos Rivers C, Colombel JF, Regueiro M, Swoger J, Schwartz M, Baidoo L, Hashash J, Barrie A, Dunn MA, Binion DG.

J Clin Gastroenterol. 2016 Jul;50(6):476-82. doi: 10.1097/MCG.0000000000000463.

PMID:
26646805
23.

Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.

Koutroumpakis E, Ramos-Rivers C, Regueiro M, Hashash JG, Barrie A, Swoger J, Baidoo L, Schwartz M, Dunn MA, Koutroubakis IE, Binion DG.

Dig Dis Sci. 2016 Mar;61(3):865-71. doi: 10.1007/s10620-015-3932-1. Epub 2015 Oct 29.

PMID:
26514677
24.

Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort.

Koutroubakis IE, Ramos-Rivers C, Regueiro M, Koutroumpakis E, Click B, Schwartz M, Swoger J, Baidoo L, Hashash JG, Barrie A, Dunn MA, Binion DG.

J Clin Gastroenterol. 2016 Sep;50(8):638-43. doi: 10.1097/MCG.0000000000000417.

25.

Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis.

Koutroubakis IE, Regueiro M, Schoen RE, Ramos-Rivers C, Hashash JG, Schwartz M, Swoger J, Barrie A, Baidoo L, Dunn MA, Hartman D, Binion DG.

Inflamm Bowel Dis. 2016 Jan;22(1):100-5. doi: 10.1097/MIB.0000000000000587.

PMID:
26355468
26.

Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study.

Hashash JG, Chintamaneni P, Ramos Rivers CM, Koutroubakis IE, Regueiro MD, Baidoo L, Swoger JM, Barrie A, Schwartz M, Dunn MA, Binion DG.

Inflamm Bowel Dis. 2015 Nov;21(11):2576-82. doi: 10.1097/MIB.0000000000000534.

PMID:
26296061
27.

Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease.

Seminerio JL, Koutroubakis IE, Ramos-Rivers C, Hashash JG, Dudekula A, Regueiro M, Baidoo L, Barrie A, Swoger J, Schwartz M, Weyant K, Dunn MA, Binion DG.

Inflamm Bowel Dis. 2015 Dec;21(12):2857-63. doi: 10.1097/MIB.0000000000000560.

PMID:
26241001
28.

Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent Hospitalization.

Click B, Vargas EJ, Anderson AM, Proksell S, Koutroubakis IE, Ramos Rivers C, Hashash JG, Regueiro M, Watson A, Dunn MA, Schwartz M, Swoger J, Baidoo L, Barrie A 3rd, Binion DG.

Inflamm Bowel Dis. 2015 Oct;21(10):2254-61. doi: 10.1097/MIB.0000000000000516.

PMID:
26197446
29.

Cutaneous Manifestations of Crohn Disease.

Hagen JW, Swoger JM, Grandinetti LM.

Dermatol Clin. 2015 Jul;33(3):417-31. doi: 10.1016/j.det.2015.03.007. Review.

PMID:
26143422
30.

Decrease in Cell Volume Generates Contractile Forces Driving Dorsal Closure.

Saias L, Swoger J, D'Angelo A, Hayes P, Colombelli J, Sharpe J, Salbreux G, Solon J.

Dev Cell. 2015 Jun 8;33(5):611-21. doi: 10.1016/j.devcel.2015.03.016. Epub 2015 May 14.

31.

The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease.

Koutroubakis IE, Ramos-Rivers C, Regueiro M, Koutroumpakis E, Click B, Schwartz M, Swoger J, Baidoo L, Hashash JG, Barrie A, Dunn MA, Binion DG.

Inflamm Bowel Dis. 2015 Jul;21(7):1587-93. doi: 10.1097/MIB.0000000000000417.

32.

Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease.

Koutroubakis IE, Ramos-Rivers C, Regueiro M, Koutroumpakis E, Click B, Schoen RE, Hashash JG, Schwartz M, Swoger J, Baidoo L, Barrie A, Dunn MA, Binion DG.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1760-6. doi: 10.1016/j.cgh.2015.03.029. Epub 2015 Apr 8.

33.

Editorial: drug monitoring targets for optimising adalimumab in Crohn's disease.

Swoger JM, Levesque BG.

Aliment Pharmacol Ther. 2014 Oct;40(7):854-5. doi: 10.1111/apt.12911. No abstract available.

34.

Reply: To PMID 24440221.

Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1764-5. doi: 10.1016/j.cgh.2014.06.015. Epub 2014 Jun 20. No abstract available.

PMID:
24956081
35.

Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops.

Swoger JM, Regueiro M.

Inflamm Bowel Dis. 2014 May;20(5):926-35. doi: 10.1097/MIB.0000000000000002. Review.

PMID:
24651584
36.

Reply: To PMID 24530602.

Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W.

Clin Gastroenterol Hepatol. 2014 Aug;12(8):1407. doi: 10.1016/j.cgh.2014.03.002. Epub 2014 Mar 12. No abstract available.

PMID:
24614332
37.

OPTiSPIM: integrating optical projection tomography in light sheet microscopy extends specimen characterization to nonfluorescent contrasts.

Mayer J, Robert-Moreno A, Danuser R, Stein JV, Sharpe J, Swoger J.

Opt Lett. 2014 Feb 15;39(4):1053-6. doi: 10.1364/OL.39.001053.

PMID:
24562276
38.

Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.

Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W.

Clin Gastroenterol Hepatol. 2014 Sep;12(9):1494-502.e1. doi: 10.1016/j.cgh.2013.12.035. Epub 2014 Jan 16.

PMID:
24440221
39.

Imaging MDCK cysts with a single (selective) plane illumination microscope.

Swoger J, Pampaloni F, Stelzer EH.

Cold Spring Harb Protoc. 2014 Jan 1;2014(1):114-8. doi: 10.1101/pdb.prot080184.

PMID:
24371325
40.

Imaging cellular spheroids with a single (selective) plane illumination microscope.

Swoger J, Pampaloni F, Stelzer EH.

Cold Spring Harb Protoc. 2014 Jan 1;2014(1):106-13. doi: 10.1101/pdb.prot080176.

PMID:
24371324
41.

Light-sheet-based fluorescence microscopy for three-dimensional imaging of biological samples.

Swoger J, Pampaloni F, Stelzer EH.

Cold Spring Harb Protoc. 2014 Jan 1;2014(1):1-8. doi: 10.1101/pdb.top080168.

PMID:
24371323
42.

Association between telephone activity and features of patients with inflammatory bowel disease.

Ramos-Rivers C, Regueiro M, Vargas EJ, Szigethy E, Schoen RE, Dunn M, Watson AR, Schwartz M, Swoger J, Baidoo L, Barrie A, Dudekula A, Youk AO, Binion DG.

Clin Gastroenterol Hepatol. 2014 Jun;12(6):986-94.e1. doi: 10.1016/j.cgh.2013.11.015. Epub 2013 Nov 19.

43.

Intravital imaging of hair-cell development and regeneration in the zebrafish.

Pinto-Teixeira F, Muzzopappa M, Swoger J, Mineo A, Sharpe J, López-Schier H.

Front Neuroanat. 2013 Oct 11;7:33. doi: 10.3389/fnana.2013.00033. eCollection 2013.

44.

Ultra-high C-reactive protein levels in hospitalized inflammatory bowel disease (IBD) patients predicts serious complications.

Clarke K, Hashash JG, Swoger JM, Regueiro M.

Int J Colorectal Dis. 2014 Jan;29(1):133. doi: 10.1007/s00384-013-1737-2. Epub 2013 Jul 9. No abstract available.

PMID:
23836113
45.

Naive B-cell trafficking is shaped by local chemokine availability and LFA-1-independent stromal interactions.

Coelho FM, Natale D, Soriano SF, Hons M, Swoger J, Mayer J, Danuser R, Scandella E, Pieczyk M, Zerwes HG, Junt T, Sailer AW, Ludewig B, Sharpe J, Figge MT, Stein JV.

Blood. 2013 May 16;121(20):4101-9. doi: 10.1182/blood-2012-10-465336. Epub 2013 Apr 4.

46.

Tumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting system.

Kip KE, Swoger JM, Grandinetti LM, Barrie AM 3rd, Greer JB, Regueiro MD.

Inflamm Bowel Dis. 2013 May;19(6):1164-72. doi: 10.1097/MIB.0b013e31828075bd.

PMID:
23518804
47.

Quantitative measurements in 3-dimensional datasets of mouse lymph nodes resolve organ-wide functional dependencies.

Mayer J, Swoger J, Ozga AJ, Stein JV, Sharpe J.

Comput Math Methods Med. 2012;2012:128431. doi: 10.1155/2012/128431. Epub 2012 Sep 16.

48.

Image formation by linear and nonlinear digital scanned light-sheet fluorescence microscopy with Gaussian and Bessel beam profiles.

Olarte OE, Licea-Rodriguez J, Palero JA, Gualda EJ, Artigas D, Mayer J, Swoger J, Sharpe J, Rocha-Mendoza I, Rangel-Rojo R, Loza-Alvarez P.

Biomed Opt Express. 2012 Jul 1;3(7):1492-505. doi: 10.1364/BOE.3.001492. Epub 2012 Jun 4.

49.

Maximizing the effect of biologics in inflammatory bowel disease.

Souto Rodriguez R, Swoger JM, Barreiro-De Acosta M, Regueiro M.

Minerva Gastroenterol Dietol. 2012 Jun;58(2):101-22. Review.

PMID:
22643594
50.

Evaluation for postoperative recurrence of Crohn disease.

Swoger JM, Regueiro M.

Gastroenterol Clin North Am. 2012 Jun;41(2):303-14. doi: 10.1016/j.gtc.2012.01.011. Review.

PMID:
22500519

Supplemental Content

Loading ...
Support Center